Skip to main content
PLOS One logoLink to PLOS One
. 2020 Oct 22;15(10):e0239991. doi: 10.1371/journal.pone.0239991

Cats shedding pathogenic Leptospira spp.—An underestimated zoonotic risk?

Roswitha Dorsch 1,*, Javier Ojeda 2, Miguel Salgado 3, Gustavo Monti 3, Bernadita Collado 3, Camillo Tomckowiack 4, Carlos Tejeda 3, Ananda Müller 2,¤, Theo Eberhard 5, Henricus L B M Klaasen 6, Katrin Hartmann 1
Editor: Kalimuthusamy Natarajaseenivasan7
PMCID: PMC7580889  PMID: 33091006

Abstract

Shedding of DNA of pathogenic Leptospira spp. has been documented in naturally infected cats in several countries, but urinary shedding of infectious Leptospira spp. has only recently been proven. The climate in Southern Chile is temperate rainy with high annual precipitations which represents ideal preconditions for survival of Leptospira spp., especially during spring and summer. The aims of this study were to investigate shedding of pathogenic Leptospira spp. in outdoor cats in Southern Chile, to perform molecular characterization of isolates growing in culture, and to assess potential risk factors associated with shedding. Urine samples of 231 outdoor cats from rural and urban areas in southern Chile were collected. Urine samples were investigated for pathogenic Leptospira spp. by 4 techniques: qPCR targeting the lipL32 gene, immunomagnetic separation (IMS)-coupled qPCR (IMS-qPCR), direct culture and IMS-coupled culture. Positive urine cultures were additionally confirmed by PCR. Multilocus sequence typing (MLST) was used to molecularly characterize isolates obtained from positive cultures. Overall, 36 urine samples (15.6%, 95% confidence interval (CI) 11.4–20.9) showed positive results. Eighteen (7.8%, 95% CI 4.9–12.1), 30 (13%, 95% CI 9.2–18), 3 (1.3%, 0.3–3.9) and 4 cats (1.7%; 95% CI 0.5–4.5) were positive in qPCR, IMS-qPCR, conventional culture, and IMS-coupled culture, respectively. MLST results of 7 culture-positive cats revealed sequences that could be assigned to sequence type 17 (6 cats) and sequence type 27 (1 cat) corresponding to L. interrogans (Pathogenic Leptospira Subgroup 1). Shedding of pathogenic Leptospira spp. by cats might be an underestimated source of infection for other species including humans. The present study is the first one reporting growth of leptospires from feline urine in culture in naturally infected cats in South-America and characterisation of culture-derived isolates. So far, very few cases of successful attempts to culture leptospires from naturally infected cats are described worldwide.

Introduction

Leptospirosis is a worldwide zoonotic disease affecting most mammalian species. Prevalence of Leptospira species (spp.) infection is associated with certain environmental conditions and shows a positive association with increased rainfall and temperatures [14]. Leptospires survive for months in water and moist soil. Contamination of the environment with pathogenic Leptospira spp. mainly occurs via urinary shedding of reservoir hosts, such as small rodents that are considered the most important reservoir species. These species usually do not show clinical signs after infection but harbor leptospires in their renal tubules and shed them for prolonged periods of time [5]. In livestock animals (cows and pigs), leptospirosis causes chronic infections affecting fertility and reproduction [6, 7].

Only few reports of clinical cases of leptospirosis in cats are published [810], and Leptospira spp. infection appears to be underinvestigated in cats compared to other animal species. It has, however, been demonstrated that cats can be infected and develop specific antibodies [11, 12]. Reported antibody prevalence in naturally infected cats ranges from 0.8% to 33.3%, depending on the geographic area and the cats´ lifestyle [1316]. The highest prevalence of antibody-positive cats have been found in Greece (33.3%) [17] and in rural areas of Southern Chile (25.2%) [18]. In addition, there are reports that infection with pathogenic Leptospira spp. in cats might be, although rarely, associated with acute kidney injury or liver disease but also with the development of chronic kidney disease. A study from Canada identified a significantly higher antibody prevalence in cats with chronic kidney disease (14.9%) when compared to healthy cats (7.2%) [12].

Still there are uncertainties concerning the role of cats as carrier of Leptospira spp. and their potential zoonotic risk. Few studies demonstrated shedding of Leptospira spp. in cats, first by identification of leptospiral agglutinins in the urine [19] and later by PCR [11, 12, 1416, 20]. Experimentally infected cats can shed leptospires via urine intermittently up to 10 weeks after infection with Leptospira interrogans serovar Canicola [19]. Prevalence of cats shedding pathogenic Leptospira spp. in naturally infected cats has also been documented using urine PCR, ranging from 0.8% in Thailand [15], 1.7% in Spain [16], 3.3% in Canada and Germany [12, 14], 4.9% in Malaysia [20], up to 67.8% in Taiwan [11].

The climate in Southern Chile is temperate rainy with an average temperature of 16.7°C. In the Los Rios region, the reported annual precipitations exceed 2400 mm (www.wetterkontor.de). This represents ideal environmental conditions for survival of pathogenic Leptospira spp. in the environment, particularly during spring and summer. A study performed in rural communities in Southern Chile demonstrated the ubiquity of leptospires in household environments [21]. Water samples from puddles, containers, animal troughs, rivers, canals, and drinking water from 236 households were investigated for the presence of pathogenic Leptospira spp. using PCR. Pathogenic Leptospira spp. were identified in 13.5% of all samples; e.g. in 11.3% of open containers, 14.5% of animal drinking sources, 15.8% of human drinking sources, and 19.3% of puddles. This indicates that there is a considerable risk of infection for humans and mammalian animals living in this environment. Leptospirosis has emerged to become a major public health threat in Latin America. Nevertheless, little is currently known regarding its incidence [22]. In countries, such as Peru and Chile, where leptospirosis has been studied systematically in rural areas, a large proportion of the human population has antibodies indicating previous exposure to pathogenic leptospires (36,6% and 12,0% respectively) [23, 24].

In Chile, a variable human to cat ratio ranging from 9.3:1 to 1.4:1 has been reported [25] suggesting that there is a relatively large feline population that could be a potential source of Leptospira spp. infection. So far, it is not known how many cats in this geographic area actively shed pathogenic Leptospira spp., while the reported antibody prevalence in cats in rural areas (25.2%) [18] is among the highest reported worldwide. Therefore, the role of cats as a reservoir for pathogenic Leptospira spp. could be very important.

Thus, to provide scientific knowledge for a better understanding of the role and relative importance of cats as a source of pathogenic Leptospira spp. infection, the aims of the study were: (1) to determine the proportion of cats shedding pathogenic Leptospira spp. in Southern Chile, (2) to determine the molecular profile of the cultured isolates, and (3) to identify possible risk factors regarding Leptospira spp. shedding.

Material and methods

Ethical note

Procedures were approved by the Universidad Austral de Chile Animal Care Committee (No. 269/2016). Informed written owner consent was obtained for all cats included in the study.

Study design

The sampling size was statistically estimated by assuming an expected prevalence of urinary shedding of pathogenic Leptospira of 4% with a 95% confidence interval (CI) of the estimation with a 5% precision, indicating that at least 236 cats had to be included. Between October 2016 and March 2017, cats of rural and urban origin from the Los Ríos and Los Lagos region in Southern Chile were included, trying to cover a geographic area in which a high antibody prevalence in cats had been reported previously [18].

Cats

Included cats were patients of the small animal hospital of the Universidad Austral de Chile in Valdivia presented for health issues or for elective procedures (e.g. neutering, vaccination), client-owned cats participating in castration projects offered by the city of Valdivia or other communities, and cats presented by their owners specifically for study enrolement. Cats were offered one free vaccination and deworming as compensation for participating, if this was clinically justifiable. Cats were excluded from the study if they had received antimicrobial treatment within the last four weeks before sampling due to a decreased likelihood for detection of Leptospira spp. even if they were infected, or if they were living exclusively indoors or had only access to a balcony because of a low risk for infection.

Sampling

Urine samples were collected via cystocentesis using a 21 G needle attached to 5 ml syringe. Cystocentesis was performed with palpation of the urinary bladder or ultrasound-guided. At the time of sampling, a physical examination was performed in each cat. A questionnaire with information about the cat and potential risk factors was answered by the owner. It included questions about signalment, living conditions, consumption of raw meat, drinking out of puddles, contact with rodents or eating rodents, and contact with other cats, dogs, or livestock and vaccination status.

Detection of pathogenic Leptospira spp. by qPCR and culture

To increase the overall diagnostic sensitivity for the detection of pathogenic Leptospira spp. in urine, four diagnostic tools were used in each sample: lipL32 quantitative qPCR, immunomagnetic-separation (IMS)-coupled with lipL32 qPCR (IMS-qPCR), culture for Leptospira spp., and IMS-coupled with culture (Fig 1).

Fig 1. Methods applied for identification of urinary shedding of pathogenic Leptospira spp.

Fig 1

Quantitative real-time lipL32 polymerase chain reaction

For each sample, at least 1 mL was centrifuged at 6,500 rpm for 15 minutes. The pellet was resuspended in 1 mL of 1X phosphate buffered saline (PBS) [137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4 (pH 7)] and then transferred to a 1.5 mL microcentrifuge tube and re-centrifuged at 11,000 rpm for 5 minutes. Finally, the supernatant was discarded and the pellet was resuspended in 1mL of 1X PBS [26]. After this first cleaning and purification step, 100 μL were separated for a pretreatment step of immune-separation (see below) before proceeding with DNA extraction and direct qPCR. The rest of the urine was subjected to a DNA extraction-purification protocol using the High Pure PCR Template Preparation kit (Roche), following the manufacturer instructions.

The DNA templates obtained were analyzed in a qPCR system (Roche LightCycler 2.0), using a TaqMan probe and targeting the lipL32 gene which is specific only for pathogenic Leptospira spp. [26]. The amplification mixture for each sample included 0.7 μM primers, 0.15 μM probe, 10 μL Master Mix TaqMan universal (Roche) and 5 μL DNA template, in a total volume of 20 μL. Samples were amplified with the following program: Initial denaturation at 95°C for 2 min, followed by 40 cycles of denaturation for 5 s at 95°C for 5 and annealing/elongation for 30 s at 58°C [26, 27]. The PCR system included a negative and positive control in order to survey the proficiency of the reaction as well as DNA extraction-negative and -positive controls. The positive control for both, DNA extraction and PCR protocols, corresponded to a pure culture of pathogenic Leptospira spp. in two dilutions with a known concentration of leptospires (104/mL and 102/mL), where the two dilutions were used. Amplification efficiency (E) was calculated from the slope of the standard curve in each run using the following formula (E = 10−1/slope).

Immunomagnetic-separation (IMS)-coupled lipL32 quantitative polymerase chain reaction

The urine sample aliquot was pre-treated with an IMS method published previously [28], followed by a DNA extraction purification and molecular confirmation qPCR. The IMS-qPCR consisted of 4 steps (in silico peptide production; polyclonal antibody production; coating magnetic beads with polyclonal antibodies, and IMS–qPCR Leptospira spp. detection). The magnetic separation of pathogenic Leptospira spp. from urine samples and the subsequent washing steps were carried out using the automated BeadRetrieverTM System (Invitrogen Life Technologies, Grand Island, NY). Pathogenic Leptospira spp. were selectively concentrated from 0.5 mL processed samples obtained from the coated magnetic beads, as described above. The final product was suspended in 0.5 mL PBS for DNA extraction purification followed by qPCR for pathogenic Leptospira spp. as described above.

Direct culture

Two dilutions of urine (1:10 and 1:100) with 5 ml of liquid Ellinghausen-McCullough-Johnson-Harris (EMJH) medium supplemeted with 5-fluorouracil (0.2 mg/ml) were prepared immediately after urine sampling. Samples were cultured at 29°C for 13 weeks according to previous recommendations [29]. In this liquid medium, growth was defined as turbidity that becomes apparent at an estimated bacterial density of 1x108 bacteria/mL. Each sample was observed for evidence of growth using dark-field microscopy for observation of viable, motile Leptospira spp. bacteria. DNA of positive isolations was used for molecular characterization using the above described extraction protocol.

Immunomagnetic separation coupled to culture

After immunomagnetic separation as described above, 100 μL of the final product were transferred into 5 ml EMJH medium and cultured at 29°C for 13 weeks. Each sample was observed for evidence of colony growth, as defined above. DNA of positive cultures was used for molecular characterization.

Estimation of pathogenic Leptospira spp. shedding load

Pathogenic Leptospira spp. cell numbers (genome equivalents) were estimated from either of the detection methods. Estimation was based on the concentration of Leptospira spp. DNA, obtained from positive samples, that was measured in a Nanoquant spectrophotometer (TECAN group, Männedorf, Schweiz) adjusted for a 106 dilution. With the reference of the molecular weight of the genome of Leptospira interrogans serovar Hardjo-prajitno (GenBank accession number EU357983.1) a standard curve for estimation of pathogenic Leptospira spp. numbers in urine using a Roche 2.0 real-time PCR, according to the following equation was established [30, 28]:

Genomeequivalent=DNAconcentration(ng/μl)×(6.022×1023mol-1)(4.659×106basepairs)×(1×109ng/g×660g/mol)(accesionnumberEU357983.1)(basemass)

Molecular characterization by multilocus sequence typing (MLST)

The "Multi Locus Sequence Typing" (MLST) method was used to molecularly characterize strains obtained from positive cultures. MLST was performed according to a protocol described by Thaipadungpanit et al. (2007) with the following housekeeping genes: glmU, pntA, sucA, tpiA, pfkB, mreA, and caiB [31]. Briefly, PCR amplification was carried out using Leptospira spp. DNA obtained from positive urine cultures, where the initial denaturation step was 94°C for 5 min, followed by 35 cycles of 94°C for 30 sec, annealing/elongation was at 50°C for 60 sec for all genes, extension was at 72°C for 50 sec, and then the final extension was at 72°C for 7 min. The PCR products were purified using the Geneaid "Gene/DNA Genetic Extraction" kit, and sequencing was done in both directions with primers initially used for PCR amplification. Sequencing was performed using the sequencer kit "BigDye Terminator v. 3.1 cycle sequencing kit (ABI)" and the automated DNA sequencer "ABI Prism 3130xl Genetic". The sequences were analyzed using the Chrommas and Bioedits programs, and these were derived from the international database for free use (https://pubmlst.org/leptospira/) to obtain the allelic profile and to assign the sequence type (ST).

Data analysis

The overall prevalence of urinary shedding (as detected by any of the 4 techniques) of pathogenic Leptospira spp. with their 95% confidence was calculated. Mann-Whitney test was used for comparison of Leptospira spp. loads between direct qPCR and IMS-qPCR. Statistical analysis to assess risk factors was performed by ordinary and mixed-logistic regression models using the location of the cat as a random slope effect to account for potential environmental heterogeneity.

The strategy for building the model consisted in obtaining unconditional models for initial screening of variables. Variables associated with the outcome (P<0.25) were eligible for inclusion in the conditional model that was built using a forward approach and a P value of 0.05 was used for interpreting the outcomes. Potential interactions were tested based on their biological significance. The best model was assessed by using the Bayesian information criterion (BIC) index as a measure of goodness-of-fit. Two analysis were performed: a) one for cats positive with any of the 4 techniques, combined as “Leptospira-shedding” cats, and b) one for “viable Leptospira-shedding” cats (culture- and IMS-coupled culture-positive cats). Analysis was done with lme4 package [32] of R (R Development Core Team (2008)) [33]. A power post hoc analysis was performed using WebPower package [34] for a evaluation of variables that were statistically not significant in the model.

Results

Shedding of pathogenic Leptospira spp.

In total, 231 cats from 11 locations at 7 municipal districts were included into the study (Fig 2). Overall, 30 cats were PCR-positive (Table 1), and 7 cats were culture-positive.

Fig 2. Map of Latin America and of the region Los Rios in Southern Chile.

Fig 2

Sampled cats originated from the 7 delineated municipal districts.

Table 1. Percentage and 95% Confidence Intervals (CI) of positive results from 231 urine samples using quantitative real-time PCR (qPCR), immunomagnetic-separation-coupled qPCR (IMS-qPCR), direct culture and IMS-coupled culture for identification of cats shedding pathogenic Leptospira spp. in urine.

Assay Percentage (number) of positive samples Estimated bacterial load/mL
% (n) 95% CI Mean 95% CI
qPCR 7.8 (18) 4.9–12.1 32.7 17–49
IMS-qPCR 13.0 (30) 9.2–18.0 1,683,123 578,206–2,788,040
Direct culture 1.3 (3) 0.3–3.9 n. d. n. d.
IMS-coupled culture 1.7 (4) 0.5–4.5 n. d. n. d.
Total 15.6 (36) 11.4–20.9 n. d. n. d.

CI = confidence interval; n. d. = not determined

All 18 cats that were positive on qPCR were also positive on IMS-qPCR (Table 2). IMS-qPCR identified 12 additional cats as shedders of pathogenic Leptospira spp. Seven cats were positive in culture, 3 cats in direct culture and 4 other cats in IMS-coupled culture. None of them was positive in both culture methods. One of the cats that was positive in IMS-coupled culture was also positive in conventional qPCR and on IMS-qPCR. The other 6 culture-positive cats were PCR-negative. Individual data on signalment and health status are illustrated in Table 2. Data of geographic distribution of positive cats are combined in Table 3.

Table 2. Signalment, origin and health status of cats with positive results on qPCR, immunomagnetic-separation (IMS)-coupled PCR (IMS-qPCR), direct culture and/or IMS-coupled culture and respective bacterial concentrations in number of genomic equivalents/mL (GE/ml).

Cat Sex Age (years) Location Status Health status qPCR GE/ml estimated by qPCR IMS- qPCR GE/mL estimated by IMS-qPCR Culture IMS-coupled culture
2 fs 1,5 Valdivia priv. ear mites, chronically ill* neg 0 neg 0 neg pos
8 fs 5 Valdivia priv. healthy neg 0 pos 119 neg neg
10 f 1,75 Valdivia priv. healthy pos 35 pos 7,160,000 neg neg
11 f 1 Valdivia priv. healthy pos 26 pos 330,000 neg neg
12 f 0,75 Valdivia priv. healthy pos 96 pos 3,380,000 neg neg
13 f 4 Valdivia priv. healthy pos 42 pos 8,380,000 neg neg
18 f 1 Paillaco priv. chronically ill* pos 19 pos 124,800 neg neg
22 f NA Lago Ranco stray cat healthy pos 3 pos 2,680 neg neg
25 fs 2 Valdivia priv. unilateral nasal discharge pos 22 pos 9,440,000 neg neg
26 mc 3 Valdivia priv. hematuria pos 16 pos 632,000 neg pos
29 mc 2 Valdivia priv. acute renal failure pos 12 pos 6,840,000 neg neg
30 m 2 Valdivia priv. ear mites chronically ill* neg 0 pos 1,178 neg neg
34 f 1 Valdivia priv. healthy pos 124 pos 562,000 neg neg
38 f 1 Lanco priv. healthy neg 0 pos 630 neg neg
40 mc 8 Lanco priv. healthy neg 0 pos 3,020 neg neg
43 f 6 Lanco priv. healthy neg 0 pos 1,966 neg neg
45 f 1 Valdivia priv. healthy pos 62 pos 6,800,000 neg neg
47 f 0,6 Valdivia priv. stomatitis neg 0 pos 14,720 neg neg
48 m 1 Valdivia priv. stomatitis neg 0 pos 16,600 neg neg
49 f 1,5 Valdivia priv. healthy neg 0 pos 566 neg neg
50 mc 4 Valdivia priv. idiopathic cystitis, urethral stricture neg 0 pos 1,804 neg neg
56 m 8 Valdivia priv. healthy pos 14 pos 4,720,000 neg neg
65 fs 4 Valdivia priv. healthy neg 0 neg 0 neg pos
66 f 1 Valdivia priv. healthy neg 0 neg 0 pos neg
67 f 3 Valdivia priv. vomiting neg 0 neg 0 pos neg
68 mc 10 Valdivia priv. oral tumor pos 8 pos 352,000 neg neg
69 m 6 Valdivia priv. mammary tumors pos 16 pos 314,000 neg neg
71 m NA Mafil priv. healthy pos 14 pos 402,000 neg neg
76 m 1 Corral priv. healthy pos 45 pos 354,000 neg neg
90 mc 5 Valdivia priv. HCM pos 19 pos 394,000 neg neg
91 m 4 Valdivia priv. healthy neg 0 neg 0 neg pos
121 f 0,4 Valdivia priv. healthy neg 0 pos 5 neg neg
130 fs 6 Valdivia priv. healthy pos 14 pos 262,000 neg neg
181 f 1,5 Valdivia priv. healthy neg 0 pos 3,480 neg neg
182 f 1,5 Valdivia priv. healthy neg 0 pos 132 neg neg
209 m 1,5 Valdivia priv. healthy neg 0 neg 0 pos neg

f = female, fs = female spayed, HCM = hypertrophic cardiomyopathy, m = male, mc = male castrated, NA = information not available, neg = negative, pos = positive, priv. = privately owned; bold = positive in the respective test;

*Cats had the habitus of a chronically ill animal presenting with a reduced body condition score, dull fur and lethargy;

Table 3. Description of sampling locations, number of cats sampled and number of cats positive in quantitative real-time PCR (qPCR) and/or immunomagnetic-separation (IMS)-coupled qPCR, as well as in direct culture and/or IMS-coupled culture.

Sampling location (Municipality) All sampled cats n PCR-positive cats n (%) Culture-positive cats n (%) All positive cats n (%)
Valdivia 186 23 (12.4) 7 (3.8) 29 (15.6)
Corral 12 1 (8.3) 0 1 (8.3)
Paillaco 10 1 (10.0) 0 0
Lanco 7 3 (42.9) 0 3 (42.9)
La Unión 6 0 0 0
Mafil 5 1 (20.0) 0 1 (20.0)
Lago Ranco 5 1 (20.0) 0 1 (20.0)
Total 231 30 (13.0) 7 (3.0) 36

Multi locus sequence typing of isolates obtained of 7 positive cultures revealed that sequences of 6 cats were identical to available sequences of L. interrogans sequence type (ST) 17, and the sequence of one cat was identical to available sequences of L. interrogans ST 27 (Table 4).

Table 4. Multi locus sequence typing of PCR products, allelic profile, and sequence types (ST) from 7 Leptospira spp.-positive urine cultures.

Cat # caiB glmU mreA pfkB pntA sucA tpiA ST Product
2 8 11 4 10 1 21 2 17 L. interrogans Icterohaemorrhagiae Copenhageni
26 8 11 4 10 2 21 65 17 L. interrogans Icterohaemorrhagiae Copenhageni
65 8 4 4 10 2 21 2 17 L. interrogans Icterohaemorrhagiae Copenhageni
66 19 11 4 10 1 21 65 17 L. interrogans Icterohaemorrhagiae Copenhageni
67 8 4 4 10 2 21 2 17 L. interrogans Icterohaemorrhagiae Copenhageni
91 8 4 4 10 1 21 2 17 L. interrogans Icterohaemorrhagiae Copenhageni
209 19 11 13 10 12 3 3 27 L. interrogans Autumnalis Autumnalis

Risk factor analyses

For unconditional model (Table 5), health status (P<0.001), eating rodents (P = 0.08), reproductive status (P = 0.11), previous vaccination (P = 0.11), and age >1 year (P = 0.12) were variables primary associated with leptospiruria, and used for building a conditional model for cats that were PCR- and/or culture positive.

Table 5. Unconditional logistic regression model results for pathogenic Leptospira spp. shedding cats (PCR- and/or culture-positive cats).

Variable Category n Leptospira spp. shedding Odds ratio 95% CI
Positive Negative
n (%) n (%)
Age ≤1 year 98 11 (11.22) 87 (88.78) Ref.
>1 year 112 23 (20.54) 89 (79.46) 1.8* 0.86–3.90
Gender Female 138 22 (15.94) 116 (84.06) Ref.
Male 89 14 (15.73) 75 (84.27) 0.98 0.46–2.02
Reproductive status Neutered 52 12 (23.07) 40 (76.92) Ref.
Intact 175 24 (13.71) 151(86.29) 0.53* 0.25–1.15
Origin Rural 81 15 (18.51) 66 (81.48) Ref.
Urban 144 20 (13.89) 124 (86.11) 0.70 0.34–1.47
Ownership Feral 11 2 (18.18) 9 (81.82) Ref.
Privatly owned 213 33 (15.49) 180 (84.51) 0.83 0.20–5.63
Weight >3kg 99 14 (14.14) 85 (85.86) Ref.
≤3 kg 96 11 (11.46) 85 (88.54) 1.22 0.79–1.86
Health status Healthy 208 23(11.06) 185 (88.94) Ref.
Sick 23 13 (56.52) 10 (43.48) 4.12* 1.81–9.23
Drinking out of puddles No 159 25 (15.72) 134 (84.28) Ref.
Yes 66 10 (15.15) 56 (84.85) 0.97 0.42–2.10
Contact with rodents No 103 14 (13.59) 89 (84.41) Ref.
Yes 122 21 (17.21) 101 (82.79) 1.35 0.65–2.86
Eating rodents No 170 22 (12.94) 148 (87.06) Ref.
Yes 43 10 (23.26) 33 (76.74) 2.08* 0.87–4.75
Consumption of raw meat No 163 28 (17.18) 135 (82.82) Ref.
Yes 53 6 (11.32) 47 (88.68) 0.64 0.24–1.58
Contact with other cats No 12 2 (16.67) 10 (83.33) Ref.
Yes 211 33 (15.64) 178 (84.36) 1.07 0.38–2.67
Contact with dogs No 49 8 (16.33) 41 (83.67) Ref.
Yes 173 27 (15.61) 146 (84.39) 0.96 0.14–3.78
Contact with livestock No 172 29 (16.86) 143 (83.12) Ref.
Yes 52 6 (11.54) 46 (88.46) 0.643 0.25–1.65
Previous vaccinations# No 121 13 (10.7) 108 (89.3) Ref.
Yes 44 9 (20.4) 35 (79.6) 2.13* 0.82–5.39

*P<0.25; CI = Confidence interval, Ref. = Reference category

# vaccinations against panleukopenia, feline herpesvirus and calicivirus and rabies in variable combinations and intervals

Conditional logistic regression after evaluating potential interactions and confounders is illustrated in Table 6 and included four risk factors. Two of them (being sick and being vaccinated) were significantly associated with shedding of pathogenic Leptospira spp. while the other two (age >1year and eating rodents) were not. The random intercept was statistically significant and accounted for 22.9% of the extra variability due to the place where the cat lived. The power estimation for this model was 90% which is considered high enough.

Table 6. Conditional logistic regression model results for pathogenic Leptospira spp. shedding cats (PCR- and/or culture-positive cats).

Variable Category Odds ratio 90% CI
Age >1 year 1.36 0.54–3.42
≤1 year Ref.
Health status Healthy Ref.
Sick 3.04* 1.10–8.39
Eating rodents No Ref.
Yes 1.20 0.40–3.55
Previous vaccinations# No Ref.
Yes 2.93* 1.18–7.24

*P<0.05; Bayesian information criterion index = 144.9

CI = confidence interval, Ref. = Reference category

# vaccinations against panleukopenia, feline herpesvirus and calicivirus and rabies in variable combinations and intervals

In addition, another model was used to evaluate potential risk factors associated with shedding of viable pathogenic Leptospira spp. (only cats positive on direct culture or IMS-coupled culture). For the unconditional models, only 3 variables were potential candidates: age >1 year, the reproductive status of the cat, and eating rodents were significantly associated with Leptospira spp.-positive urine cultures.

Although a mixed model was also assessed, comparison of the goodness-of-the-fit between both indicated that the mixed-model did not fit better. Therefore, ordinary logistic regression model results are shown. The conditional logistic regression model (Table 7) included 2 variables (age >1 year and eating rodents) that were significantly associated with shedding of viable pathogenic Leptospira spp.

Table 7. Conditional logistic regression model results for cats with positive urine cultures (direct culture and/or IMS-coupled culture) for Leptospira spp.

Variable Category Odds ratio 90% CI
Age >1 year 6.61 1.08–40.40
≤1 year Ref.
Eating rodents No Ref.
Yes 3.87 1.03–14.49

CI = confidence interval, Ref. = Reference category

Discussion

Overall, 15.6% of cats included in the study were identified as shedders of pathogenic Leptospira spp‥ This is considerably higher than the shedding rates from 0.8% to 4.9% in Thailand, Spain, Germany, Canada, and Malaysia [12, 1416, 20]. One possible explanation might be the diagnostic techniques used in the present study as the application of an additional Leptospira spp. concentration technique (IMS-qPCR) increased the proportion of Leptospira spp.-shedding cats identified by PCR from 7.8% to 13.0% (12 additional cats). With direct culture and IMS-coupled culture another 6 shedding cats were identified. Other possible explanations could be related to the humid climatic conditions in the area where the study was performed with very high annual precipitations and the types of pathogenic Leptospira spp. circulating in the study area. In the present study, serovar identification was not performed, but the culture-grown leptospires could be characterized as L. interrogans ST 17 and ST 27 (pathogenic Subgroup 1) based on MLST. Other studies using whole-genome sequencing provided evidence that strains of pathogenic leptospires differ in genetic features and virulence factors for persistence outside the host, during entry into the host, as well as for colonization and persistence within the host organism [35, 36], suggesting that not all pathogenic Leptospira spp. are equally virulent [37]. Therefore, it cannot be excluded that the identified strains in the present study might have a higher virulence or be better adapted to invade the species cat than strains in other geographic regions.

There is only one study with a much higher proportion (68%) of shedding cats in Taiwan [11]. However, this study was performed after a typhoon with an associated outbreak of leptospirosis in humans [38] and included a high proportion of stray cats (68%), whereas in the present study most of the cats were privately owned well-fed cats, and only 31% of them had been observed by their owners eating rodents. In addition, in the study from Taiwan, a different PCR technique (not a quantitative PCR) was applied and not all primers used in that study were specific for pathogenic Leptospira spp.

While PCR can detect DNA of viable and killed bacteria, culture is only positive when a sufficient number of viable Leptospira spp. is present. Recently, a study from Malaysia demonstrated cultivation of pathogenic Leptospira spp. from renal tissue in 3/82 clinically healthy shelter cats and from both, renal tissue and urine, in 1/82 of these cats [20]. In addition to that study, there is one case report of a cat with a positive Leptospira spp. culture originating from the same geographic area as the present study [10]. The present study also yielded positive Leptospira spp. culture results from feline urine. Feline urine with its higher osmolality compared to dogs and humans [39] is a hostile environment for bacterial growth and therefore could prohibit the shedding of viable Leptospira spp. in many cats. This might explain the low proportion of culture-positive cats in the present study. Low pH is another physicochemical property of the urine contributing to the defense system against bacteria [40] and Leptospira spp. do not survive well in acidic urine but remain viable in alkaline urine [41]. However, in the present study, the mean urine pH was identical in culture-positive and in culture-negative cats.

Usage of magnetic separation enhances the analytical specificity and sensitivity of the subsequent detection method, given that it helps to remove the presence of many inhibitory substances or other organisms [42]. Still, only 7 cats (3.0%) were culture-positive (3 direct culture, 4 IMS-coupled culture) compared to 30 (13.0%) PCR-positive cats. However, detection of positive cultures nevertheless demonstrates that feline urine can be a source of possible contamination of the environment with viable Leptospira spp. One possible explanation for the discrepancy in the results of direct and IMS-coupled cultures is the hypothesis that antibodies used in IMS could have a neutralizing effect for the growth of Leptospira spp. in culture.

In the present study, only 1 of the 7 culture-positive cats was also PCR-positive (qPCR and IMS-qPCR). One possible reason for the negative PCR in the culture-positive cats could be the presence of PCR inhibitors. In biologic fluids, such as urine, presence of PCR inhibitors has been reported to cause false negative PCR results [43]. However, positive controls in the present study showed hardly or no inhibition. Interestingly, a similar discrepancy was seen in the only other study in cats reporting the isolation of Leptospira spp. from feline kidneys and urine [20]. In that study, all 4 culture-positive cats had negative urine PCR results. This indicates that there might be substances/chemicals present in the PCR processing but not in the samples that are cultured that could be inhibitory for certain steps in the PCR. Other reasons might also be the level of detection on qPCR and possibly the selection of primers that do not bind to all DNA targets of Leptospira spp. However, molecular characterization of isolates later on revealed sequence types that should have been recognized by PCR.

In the present study, serovar identification was not performed. Nevertheless, it was possible to molecularly characterize isolates via MLST, and identified sequences were assigned to ST 17 and ST 27, which corresponds to L. interrogans (Pathogenic Leptospira Subgroup 1) [44]. Although the Taxonomic Subcommittee does not yet accept MLST for serovar identification, the information reported from the MLST database used in the analysis of the isolated strain in this study, reports the ST 17 as Leptospira interrogans serogroup Icterohaemorrhagiae serovar Copenhageni, and the ST 27 as L. interrogans serogroup Autumnalis serovar Autumnalis. Previously characterized Leptospira spp. isolates from cats´ kidney or urine had high similarity to Leptospira interrogans serovar Pomona (1 cat from this area of Chile) [10] or to Leptospira interrogans serovar Bataviae (4 cats from Malaysia) [20]. Whereas, Leptospira interrogans Bataviae is reported to be the most common isolated serovar in humans, dogs and rats in Malaysia [4547], L. interrogans serovar Autumnalis is among the most commonly reported serovars in dogs and cats in Chile [18, 48, 49], and antibodies against L. interrogans Icterohaemorrhagiae have previously been reported in rodents in this area [50].

Four factors (age (≤1 year/>1year), health status, eating rodents, and vaccination status) were present in the final conditional model for all Leptospira spp. shedding cats (cats positive in any of the 4 techniques), and 2 factors (age (≤1 year/>1year), eating rodents) for the “viable Leptospira spp. shedding” cats (culture- or IMS-coupled culture-positive cats).

Adult stage (>1 year) was significantly associated with leptospiruria (odds ratio 6.8, CI 90% 1.08–40,4). Previous studies already reported older age as a risk factor for Leptospira spp. infection [15, 51]. A study in Thailand identified age >4 years as the only risk factor for infection (urine qPCR-positive status and/or serum antibodies in MAT) in a multivariate analysis [15]. A possible explanation for this is longer exposure to infectious environmental sources and therefore a higher risk of being infected. It is not known how long cats remain carriers after infection or if and under which circumstances they can eliminate the infection. Risk factors for Leptospira spp. infection have been investigated in several studies. Contact of cats with livestock animals was significantly associated with presence of Leptospira spp. antibodies in a study performed in Chile [18] but such an association between shedding and contact with livestock animals was not identified in the present study.

The proportion of sick cats was significantly higher in Leptospira spp. shedding cats (36,1%) than in non-shedding cats (5,1%). Clinical cases of leptospirosis in cats are rarely described. In one case series with 3 cats and 2 further reports of single cases, cats presented with acute onset of polydipsia and polyuria, lethargy, anorexia, and hematuria, and had various degrees of kidney disease or increased liver enzymes [810]. In a more recent case report, a cat presented with a 2-months history of hematuria, had no abnormalities in serum chemistry but a marked leukocytosis [10]. One leptospiruric cat (positive in qPCR and IMS-qPCR) of the present study also suffered from acute renal failure (history of acute lethargy and anorexia, severe renal azotemia), and 2 presented with hematuria (1 cat positive in qPCR, IMS-qPCR and IMS-coupled culture, 1 cat positive in IMS-qPCR). These clinical signs could indeed be associated with leptospirosis and represent acute infection. In the other 10 sick cats with different organs affected, a causal relationship of infection with Leptospira spp. is not likely. However, the higher proportion of sick cats shedding pathogenic Leptospira spp. in the present study suggests that Leptospira spp. could be one of the etiological factors in the development of these clinical problems, and that diagnostic testing Leptospira spp. infection should also be considered in cats with relevant clinical signs. Alternatively, it could be discussed that sick cats might be immunosuppressed and that an impaired immune status increases the risk of leptospiral infection and subsequent shedding. This, however, has not been reported so far. On the other hand, sick cats shedding pathogenic Leptospira spp. could represent chronically infected individuals. It would have been interesting to further monitor these cats to see if they remained chronic shedders.

Eating rodents was found to be associated with an increased risk of shedding viable pathogenic leptospires. In general, rodents are a natural reservoir pathogenic Leptospira spp., and rats are reservoir hosts of the Icterohaemorrhagiae and Copenhageni serovars [52]. Therefore, prey–predator transmission between cats and rodents is possible by hunting and is believed to be the main source of infection in cats [12, 53]. In the contrary, a negative association between cat ownership and the presence of Leptospira antibodies in people in an urban population in North America was demonstrated, and cats appear to have a protective role by decreasing contact of people with rodents that act as reservoir hosts [54].

An unforeseen result was the statistically significant association of an increased risk of shedding pathogenic Leptospira spp. and previous vaccination against feline panleukopenia, feline herpes- and calicivirus infection and/or rabies. The reason for this association is unknown. Immunological host-pathogen processes that could affect shedding of leptospires by cats in any direction are conceivable but specific information is missing. Weather there is an interference in susceptibility of vaccinated cats to act as shedders of Leptospira spp. is an interesting aspect that should be further investigated.

Results of the present study show that cats can shed viable pathogenic Leptospira spp. and, therefore, could act as transmitters to humans and livestock. Results of PCR and culture with and without separation and concentration, taken together, showed that: i) the bacterial load in feline urine is relatively low; ii) in 90% of feline shedders it was not possible to culture the organism suggesting that viability of the bacteria in feline urine is negatively affected by the hostile environment, e.g. the relatively high osmolality of feline urine; and iii) separation and concentration followed by qPCR significantly increases the sensitivity of detection of leptospiral DNA in feline urine.

Apart from the possible negative effect on bacterial viability of the hostile environment that is provided by feline urine and the stage of disease, there is another potential cause of negative culture result. There is a known difficulty to isolate Leptospira spp. from infected hosts and get them growing in vitro. Despite the presence of viable leptospires in clinical samples of an infected host, it is in many cases very difficult to isolate the bacteria in media due to the in vivo phenotype of the host-derived bacteria and their lack of capacity to adapt to in vitro conditions. Based on this general problem with cultural isolation of Leptospira spp. from infected humans and animals, it can be concluded that, despite this difficulty, viable Leptospira spp. were detected in the urine of 7 cats, which demonstrates the zoonotic potential of this infection in cats.

Conclusion

In this region of Southern Chile, 15.6% of cats were leptospiruric and 3.0% of cats were Leptospira spp. culture-positive. The present study is one of the first reporting growth of Leptospira spp. from feline urine in culture and describing genetic characteristics of culture-derived isolates. Even though feline urine appears to be a hostile environment for leptospires, shedding cats present a potential risk for zoonotic transmission.

Supporting information

S1 Questionnaire

(DOCX)

S2 Questionnaire

(DOCX)

Acknowledgments

We thank all cat owners and cats for participation in the study.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The Bavarian Academic Center for Latin America supported the study by paying for travel expenses (between Valdivia and Munich on two occasions) for planning the study. The Dirección de Investigación y Desarollo of the Universidad Austral de Chile supported the study by covering part of the costs for the material necessary for sampling and part of additional costs, e.g. transport and compensation of owners for study participation. For compensation, all included cats were vaccinated and dewormed. MSD Animal health provided the resources for sampling, clinical investigation of cats and laboratory investigations. Part of the laboratory work was funded by Proyecto FIC 15-8 (código BIP 30421496) del Gobierno Regional de Los Ríos, Chile.

References

  • 1.Miyazato KE, Fonseca A, Caputto LZ, Rocha KC, Azzalis LA, Junqueira V, et al. Incidence of Leptospirosis infection in the East Zone of Sao Paulo City, Brazil. Int Arch Med. 2013;6(1):23 10.1186/1755-7682-6-23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Diaz JH. Recognition and management of rodent-borne infectious disease outbreaks after heavy rainfall and flooding. J La State Med Soc. 2014;166(5):186–92. . [PubMed] [Google Scholar]
  • 3.Major A, Schweighauser A, Francey T. Increasing incidence of canine leptospirosis in Switzerland. Int J Environ Res Public Health. 2014;11(7):7242–60. 10.3390/ijerph110707242 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Benacer D, Thong KL, Min NC, Verasahib KB, Galloway RL, Hartskeerl RA, et al. Epidemiology of human leptospirosis in Malaysia, 2004–2012. Acta Trop. 2016;157:162–8. 10.1016/j.actatropica.2016.01.031 [DOI] [PubMed] [Google Scholar]
  • 5.Boey K, Shiokawa K, Rajeev S. Leptospira infection in rats: A literature review of global prevalence and distribution. PLoS Negl Trop Dis. 2019;13(8):e0007499 10.1371/journal.pntd.0007499 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lilenbaum W, Martins G. Leptospirosis in cattle: a challenging scenario for the understanding of the epidemiology. Transbound Emerg Dis. 2014;61 Suppl 1:63–8. 10.1111/tbed.12233 [DOI] [PubMed] [Google Scholar]
  • 7.Petrakovsky J, Bianchi A, Fisun H, Najera-Aguilar P, Pereira MM. Animal leptospirosis in Latin America and the Caribbean countries: reported outbreaks and literature review (2002–2014). Int J Environ Res Public Health. 2014;11(10):10770–89. 10.3390/ijerph111010770 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bryson DG, Ellis WA. Leptospirosis in a British domestic cat. J Small Anim Pract. 1976;17(7):459–65. 10.1111/j.1748-5827.1976.tb06986.x [DOI] [PubMed] [Google Scholar]
  • 9.Arbour J, Blais MC, Carioto L, Sylvestre D. Clinical leptospirosis in three cats (2001–2009). J Am Anim Hosp Assoc. 2012;48(4):256–60. 10.5326/JAAHA-MS-5748 [DOI] [PubMed] [Google Scholar]
  • 10.Ojeda J, Salgado M, Encina C, Santamaria C, Monti G. Evidence of interspecies transmission of pathogenic Leptospira between livestock and a domestic cat dwelling in a dairy cattle farm. J Vet Med Sci. 2018;80(8):13058 10.1292/jvms.16-0361 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chan KW, Hsu YH, Hu WL, Pan MJ, Lai JM, Huang KC, et al. Serological and PCR detection of feline leptospira in southern Taiwan. Vector Borne Zoonotic Dis. 2014;14(2):118–23. 10.1089/vbz.2013.1324 [DOI] [PubMed] [Google Scholar]
  • 12.Rodriguez J, Blais MC, Lapointe C, Arsenault J, Carioto L, Harel J. Serologic and urinary PCR survey of leptospirosis in healthy cats and in cats with kidney disease. J Vet Intern Med. 2014;28(2):284–93. 10.1111/jvim.12287 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Markovich JE, Ross L, McCobb E. The prevalence of leptospiral antibodies in free roaming cats in Worcester County, Massachusetts. J Vet Intern Med. 2012;26(3):688–689. 10.1111/j.1939-1676.2012.00900.x [DOI] [PubMed] [Google Scholar]
  • 14.Weis S, Rettinger A, Bergmann M, Llewellyn JR, Pantchev N, Straubinger RK, et al. Detection of Leptospira DNA in urine and presence of specific antibodies in outdoor cats in Germany. J Feline Med Surg. 2017;19(4):470–6. 10.1177/1098612X16634389 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sprissler F, Jongwattanapisan P, Luengyosluechakul S, Pusoonthornthum R, Prapasarakul N, Kurilung A, et al. Leptospira infection and shedding in cats in Thailand. Transbound Emerg Dis. 2019;66(2):948–56. 10.1111/tbed.13110 [DOI] [PubMed] [Google Scholar]
  • 16.Murillo A, Cuenca R, Serrano E, Marga G, Ahmed A, Cervantes S, et al. Leptospira Detection in Cats in Spain by Serology and Molecular Techniques. Int J Environ Res Public Health. 2020;17(5). 10.3390/ijerph17051600 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mylonakis ME, Bourtzi-Hatzopoulou E, Koutinas AF, Petridou E, Saridomichelakis MN, Leontides L, et al. Leptospiral seroepidemiology in a feline hospital population in Greece. Vet Rec. 2005;156(19):615–6. 10.1136/vr.156.19.615 [DOI] [PubMed] [Google Scholar]
  • 18.Azocar-Aedo L, Monti G, Jara R. Leptospira spp. in Domestic Cats from Different Environments: Prevalence of Antibodies and Risk Factors Associated with the Seropositivity. Animals (Basel). 2014;4(4):612–26. 10.3390/ani4040612 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Larsson CE, Santa Rosa CA, Larsson MH, Birgel EH, Fernandes WR, Paim GV. Laboratory and clinical features of experimental feline leptospirosis. International journal of zoonoses. 1985;12(2):111–9. [PubMed] [Google Scholar]
  • 20.Alashraf AR, Lau SF, Khairani-Bejo S, Khor KH, Ajat M, Radzi R, et al. First report of pathogenic Leptospira spp. isolated from urine and kidneys of naturally infected cats. PLoS One. 2020;15(3):e0230048 10.1371/journal.pone.0230048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Munoz-Zanzi C, Mason MR, Encina C, Astroza A, Romero A. Leptospira contamination in household and environmental water in rural communities in southern Chile. Int J Environ Res Public Health. 2014;11(7):6666–80. 10.3390/ijerph110706666 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.World Health Organization. Human leptospirosis: guidance for diagnosis, surveillance and control. 2003. World Health Organization 2003. https://apps.who.int/iris/handle/10665/42667
  • 23.Silva-Díaz H, Llatas-Cancino DN, Campos-Sánchez MJ, Aguilar FR, Mera-Villasis KM, Valderrama Y. Leptospirosis frequency and socio-demographic characteristics associated in febrile patients from northern Perú. Rev Chilena Infectol. 2015;32(5): 530–5. [DOI] [PubMed] [Google Scholar]
  • 24.Terrazas S, Olea A; Riedemann S, Torres M., Marisa. Prevalence of leptospirosis in adults in Chile, 2003. Rev Chil Infectol. 2012;29, 641–647. [DOI] [PubMed] [Google Scholar]
  • 25.Morales MA, Ibarra L, Varas C. Caracterización de la población de gatos en viviendas de la ciudad de Viña del Mar, Chile. Avances en Ciencias Veterinarias 2006;21:27–32. [Google Scholar]
  • 26.Stoddard RA, Gee JE, Wilkins PP, McCaustland K, Hoffmaster AR. Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the LipL32 gene. Diagn Microb Inf Dis. 2009;64(3):247–55. 10.1016/j.diagmicrobio.2009.03.014 [DOI] [PubMed] [Google Scholar]
  • 27.Salgado M, Otto B, Moroni M, Sandoval E, Reinhardt G, Boqvist S, et al. Isolation of Leptospira interrogans serovar Hardjoprajitno from a calf with clinical leptospirosis in Chile. BMC Vet Res. 2015;11:66 10.1186/s12917-015-0369-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Tomckowiack C, Henriquez C, Ramirez-Reveco A, Muñoz P, Collado B, Herzberg D, et al. Analytical evaluation of an immunomagnetic separation-PCR assay to detect pathogenic Leptospira in cattle urine samples obtained under field conditions. J Vet Diagn Investig. 2020. (accepted for publication) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Faine S, Adler B, Bolin CA, Perolat P. Leptospira and Leptospirosis 2nd ed Melbourne, MediSci Press; 1999. [Google Scholar]
  • 30.Dzieciol M, Volgger P, Khol J, Baumgartner W, Wagner M, Hein I. A novel real-time PCR assay for specific detection and quantification of Mycobacterium avium subsp. paratuberculosis in milk with the inherent possibility of differentiation between viable and dead cells. BMC research notes. 2010;3:251 10.1186/1756-0500-3-251 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Thaipadungpanit J, Wuthiekanun V, Chierakul W, Smythe LD, Petkanchanapong W, Limpaiboon R, et al. A dominant clone of Leptospira interrogans associated with an outbreak of human leptospirosis in Thailand. PLoS Negl Trop Dis. 2007;1(1):e56 10.1371/journal.pntd.0000056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bates D, Mächler M, Bolker B, Walker S (2015). “Fitting Linear Mixed-Effects Models Using lme4.” Journal of Statistical Software, 67(1), 1–48. 10.18637/jss.v067.i01 [DOI] [Google Scholar]
  • 33.R Development Core Team (2008). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org.
  • 34.Zhang Z, Yuan KH. Practical statistical Power analysis using Webpower and R. ISDSA Press; 2018. [Google Scholar]
  • 35.Jorge S, Kremer FS, Oliveira NR, Navarro G, Guimaraes AM, Sanchez CD, et al. Whole-genome sequencing of Leptospira interrogans from southern Brazil: genetic features of a highly virulent strain. Mem Inst Oswaldo Cruz. 2018;113(2):80–6. 10.1590/0074-02760170130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Evangelista KV, Coburn J. Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses. Future Microbiol. 2010;5(9):1413–25. 10.2217/fmb.10.102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Picardeau M. Virulence of the zoonotic agent of leptospirosis: still terra incognita? Nat Rev Microbiol. 2017;15(5):297–307. 10.1038/nrmicro.2017.5 [DOI] [PubMed] [Google Scholar]
  • 38.Su HP, Chan TC, Chang CC. Typhoon-related leptospirosis and melioidosis, Taiwan, 2009. Emerg Infect Dis. 2011;17(7):1322–24. 10.3201/eid1707.101050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Rubini ME, Wolf AV. Refractometric determination of total solids and water of serum and urine. J Biol Chem. 1957;225(2):869–76. [PubMed] [Google Scholar]
  • 40.Smee N, Loyd K, Grauer G. UTIs in small animal patients: Part 1: Etiology and pathogenesis. J Am Anim Hosp Assoc 2013;49:1–7. 10.5326/jaaha-ms-5943 [DOI] [PubMed] [Google Scholar]
  • 41.Levett PN. Leptospirosis. Clin. Microbiol. Rev. 2001,14(2):296 10.1128/CMR.14.2.296-326.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Fernandes CP, Seixas FK, Coutinho ML, Vasconcellos FA, Moreira AN, Conceicao FR, et al. An immunomagnetic separation-PCR method for detection of pathogenic Leptospira in biological fluids. Hybridoma (Larchmt). 2008;27(5):381–386. 10.1089/hyb.2008.0029 [DOI] [PubMed] [Google Scholar]
  • 43.Lantz PG, Abu al-Soud W, Knutsson R, Hahn-Hagerdal B, Radstrom P. Biotechnical use of polymerase chain reaction for microbiological analysis of biological samples. Biotechnol Annu Rev. 2000;5:87–130. 10.1016/s1387-2656(00)05033-x [DOI] [PubMed] [Google Scholar]
  • 44.Xu Y, Zhu Y, Wang Y, Chang YF, Zhang Y, Jiang X, et al. Whole genome sequencing revealed host adaptation-focused genomic plasticity of pathogenic Leptospira. Sci Rep. 2016;6:20020 10.1038/srep20020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Shafei MN, Sulong MR, Yaacob NA, Hassan H, Wan Mohamad WMZ, Daud A, et al. Seroprevalence of Leptospirosis among Town Service Workers in Northeastern State of Malaysia. Int J Collab Res Intern Med Public Health. 2012;4(4):395–403. [Google Scholar]
  • 46.Khor KH, Tan WX, Lau SF, Mohd AR, Rozanaliza R, Siti KB, et al. Seroprevalence and molecular detection of leptospirosis from a dog shelter. Trop Biomed. 2016;33(2):276–84. [PubMed] [Google Scholar]
  • 47.Benacer D, Mohd Zain SN, Sim SZ, Mohd Khalid MK, Galloway RL, Souris M, et al. Determination of Leptospira borgpetersenii serovar Javanica and Leptospira interrogans serovar Bataviae as the persistent Leptospira serovars circulating in the urban rat populations in Peninsular Malaysia. Parasit Vectors. 2016;9(1):1–11. 10.1186/s13071-016-1400-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Lelu M, Muñoz-Zanzi C, Higgins B, Galloway R. Seroepidemiology of leptospirosis in dogs from rural and slum communities of Los Rios Region, Chile. BMC Vet Res. 2015;11:31 10.1186/s12917-015-0341-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Azocar-Aedo L, Monti G. Meta-Analyses of Factors Associated with Leptospirosis in Domestic Dogs. Zoonoses and public health. 2015. 10.1111/zph.12236 [DOI] [PubMed] [Google Scholar]
  • 50.Perret PC, Abarca VK, Dabanch PJ, Solari GV, García CP, Carrasco LS, et al. Prevalencia y presencia de factores de riesgo de leptospirosis en una población de riesgo de la Región Metropolitana. Rev Méd Chile. 2005;133:426–31. 10.4067/s0034-98872005000400005 [DOI] [PubMed] [Google Scholar]
  • 51.Larsson CE, Santa Rosa CA, Hagiwara MK, Paim GV, Guerra JL. Prevalence of feline leptospirosis: serologic survey and attempts of isolation and demonstration of the agent. Int J Zoonoses. 1984;11(2):161–9. [PubMed] [Google Scholar]
  • 52.Miraglia F, de Morais ZM, Dellagostin OA, Seixas FK, Freitas JC, Zacarias FG, et al. Molecular and serological characterization of Leptospira interrogans serovar Canicola isolated from dogs, swine, and bovine in Brazil. Trop Anim Health Prod. 2013;45(1):117–21. 10.1007/s11250-012-0181-6 [DOI] [PubMed] [Google Scholar]
  • 53.Hartmann K, Egberink H, Pennisi MG, Lloret A, Addie D, Belak S, et al. Leptospira species infection in cats: ABCD guidelines on prevention and management. J Feline Med Surg. 2013;15(7):576–81. 10.1177/1098612X13489217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Childs JE, Schwartz BS, Ksiazek TG, Graham RR, LeDuc JW, Glass GE. Risk factors associated with antibodies to leptospires in inner-city residents of Baltimore: a protective role for cats. Am J Public Health. 1992;82(4):597–99. 10.2105/ajph.82.4.597 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Kalimuthusamy Natarajaseenivasan

23 Jul 2020

PONE-D-20-16002

Cats shedding pathogenic Leptospira spp. – an underestimated zoonotic risk?

PLOS ONE

Dear Dr. Dorsch,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Estimation of shedding load formula need appropriate reference support. Information about the pH of the urine sample give some clue to improvise the isolation methods.

==============================

Please submit your revised manuscript by August 21, 2020. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Kalimuthusamy Natarajaseenivasan

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Methods section, please provide additional details regarding participant consent from the owners of the animals. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal). If the need for consent was waived by the ethics committee, please include this information.

3. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

4. In your Methods section, please state where the participants were recruited for your study.

5.We note that [Figure(s) 2] in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1.    You may seek permission from the original copyright holder of Figure(s) [2] to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2.    If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

6.Thank you for stating the following financial disclosure:

 [Bavarian Academic Center for Latin America supported the study by paying for travel expenses (between Valdivia and Munich on two occasions) for planing the study. The Dirección de Investigación y Desarollo of the Universidad Austral de Chile supported the study by covering part of the costs for the material necessary for sampling and part of additional costs, e.g. transport and compensation of owners for study participation. For compensation, all included cats were vaccinated and dewormed. MSD Animal health provided the resources for sampling, clinical investigation of cats and all laboratory investigations. H.L.B.M. Klaasen is an employee of a company (MSD Animal Health) developing and marketing animal vaccines and pharmaceuticals. He contributed in preparation of the the mansucript and had valuable input in interpretation of the data. ].               

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

7.Thank you for stating the following in the Competing Interests section:

[H.L.B.M. Klaasen is an employee of a company (MSD Animal Health) developing and marketing animal vaccines and pharmaceuticals. Otherwise the authors declare that they have no conflict of interest with respect to the research, authorship and/or publication of this article.].

Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

Additional Editor Comments (if provided):

The qPCR technique using LipL32 need the reference support to know the probe details in the method section. Really wonder to notice that out of the 7 culture/IM culture positive cases just one turned to be positive for PCR and the justification of presence of PCR inhibitors in the urine need more authentication. If it is the case, then it reflects on the negative samples as false negatives due to the PCR inhibitors. Since they have used the high pure PCR template preparation kit and practically, they give high pure genomic DNA without any inhibitors. Authors need to explain it well in the discussion.

Estimation of shedding load formula need appropriate reference support.

Is there any information about the pH of the collected urine sample. That would give some idea to improvise the isolation frequency.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: It is a well-structured document with scientific rigour. The description of the methodology should be improved, for another researcher to reproduce the experiments described.

For details, please see the attached document.

Reviewer #2: The purposes of this study were to determine the proportion of cats shedding pathogenic Leptospira in Southern Chile, to determine the molecular profile of the cultured isolates, and to identify possible risk factors regarding Leptospira spp. shedding.

I think the results of this paper are definitely very interesting and highlight the importance of further investigating leptospirosis in cats. However, there are still some issues need to be addressed before further consideration.

Abstract:

Line 25: Change the Leptospira to Leptospira spp.

Line 26: This sentence need to be rephrased as in the reference 19, it has been reported from urine and kidney.

Line 33: Immunomagnetic

Introduction:

Line 59: should be under investigated rather than rarely suffer.

Line 63: The proportions were also very much depending on samples size and laboratory techniques used. Prevalence is more commonly used. Suggest changing the proportions to prevalence.

Line 69-76: Suggest shortening the paragraph.

Line 84-86: This was the result obtained from previous publication, it will be more informative if authors can share about the importance of that finding.

Line 87: How big is the human population? Since this paper concerns about the role of cats in leptospirosis. Strongly suggest the authors to add in human leptospirosis in Chile in the introduction in order to highlight how severe is the problem in human and lead to the investigating in companion animal.

Material and methods:

Line 104: Does the locations and time of sampling affected the result?

Line 111: would suggest providing a justification for the inclusion for outdoor cat only in discussion part. The definition of outdoor need to be specified. Roam freely? Community cat?

Line 117: The physical examination was performed by who? Was there any consent from owner?

Line 124: MAT is always the gold standard in investigating leptospirosis. Is there any reason why it was not performed?

Line 123: There is lack of justification the usage of qPCR, IMS-qPCR, culture and IMS-coupled culture concurrently in this study. From the line 336 to 346, IMS-qPCR was reported to be more sensitive than qPCR from the previous study. Hence, is the comparison between the different techniques also one of the objectives of the study?

Table 2

Please be more specific about the chronically ill. Would like to know what type of illness.

Discussion:

Line 332: The recruited cats were not indoor, hence, how accurate the owner can observe about the rat-hunting and eating behaviour?

Line 349-351: Since it has been reported before, I will recommend removing “first one”.

Line 355-356: Need to discuss a little bit about the findings obtained from direct culture and IMS-coupled culture. Why there were certain samples positive with direct culture, some with IMS-coupled culture?

Line 424-425: it also affected by the stage pf the leptospirosis

Line 427: that should be one of the aims of the study

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Andrea Murillo-Review.docx

Attachment

Submitted filename: Feedback for Plos one .docx

Decision Letter 1

Kalimuthusamy Natarajaseenivasan

17 Sep 2020

Cats shedding pathogenic Leptospira spp. – an underestimated zoonotic risk?

PONE-D-20-16002R1

Dear Dr. Dorsch,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Kalimuthusamy Natarajaseenivasan

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: you have done a great job, I am sure the results of your study help to improve the knowledge of leptospira infection in cats.

Just a small mistake on line 122 the word AND is repeated.

Reviewer #2: All the comments have been addressed and I truly enjoy reading this manuscript. This manuscript is important to bridge the current lacking information in the role of companion animals in leptospirosis.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Kalimuthusamy Natarajaseenivasan

14 Oct 2020

PONE-D-20-16002R1

Cats shedding pathogenic Leptospira spp. – an underestimated zoonotic risk?

Dear Dr. Dorsch:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Kalimuthusamy Natarajaseenivasan

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Questionnaire

    (DOCX)

    S2 Questionnaire

    (DOCX)

    Attachment

    Submitted filename: Andrea Murillo-Review.docx

    Attachment

    Submitted filename: Feedback for Plos one .docx

    Attachment

    Submitted filename: Response to reviewers (1).docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES